JOSEPH L. GOLDSTEIN, M.D. - Corporate Board Profile

REGENERON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2016-04-26	JOSEPH L. GOLDSTEIN, M.D., 75, has been a Director of the Company since June 1991. Dr. Goldstein has been a Professor of Molecular Genetics and Internal Medicine and the Chairman of the Department of Molecular Genetics at The University of Texas Southwestern Medical Center at Dallas since 1977. Dr. Goldstein is a member of the National Academy of Sciences, the National Academy of Medicine, and the Royal Society (London). He also serves on the Boards of Trustees of The Rockefeller University and the Howard Hughes Medical Institute. Drs. Goldstein and Brown jointly received the Nobel Prize for Physiology or Medicine in 1985 and the U.S. National Medal of Science in 1988. Dr. Goldstein's extensive research experience, his distinguished scientific and academic credentials, including his receipt of the Nobel Prize for Physiology or Medicine in 1985, and his substantial understanding of the Company gained through his service as a director since 1991, led to the board's decision to nominate Dr. Goldstein for reelection to the board.
2017-04-25	Dr. Goldstein has been a Professor of Molecular Genetics and Internal Medicine and the Chairman of the Department of Molecular Genetics at The University of Texas Southwestern Medical Center at Dallas since 1977. ... Dr. Goldstein’s extensive research experience, his distinguished scientific and academic credentials, including his receipt of the Nobel Prize for Physiology or Medicine in 1985, and his substantial understanding of the Company gained through his service as a director since 1991, led to the board’s decision to nominate Dr. Goldstein for reelection to the board. ... Compensation of Directors: Joseph L. Goldstein, M.D. 2,094,085.
2018-04-23	JOSEPH L. GOLDSTEIN, M.D. Director since: 1991 Age: 77 Independent Dr. Goldstein has been a Professor of Molecular Genetics and Internal Medicine and the Chairman of the Department of Molecular Genetics at The University of Texas Southwestern Medical Center at Dallas since 1977. Dr. Goldstein is a member of the National Academy of Sciences, the National Academy of Medicine, and the Royal Society of London. He also serves on the Boards of Trustees of The Rockefeller University and the Howard Hughes Medical Institute. Drs. Goldstein and Brown jointly received the Nobel Prize for Physiology or Medicine in 1985 and the U.S. National Medal of Science in 1988. Dr. Goldstein's extensive research experience, his distinguished scientific and academic credentials, including his receipt of the Nobel Prize for Physiology or Medicine in 1985, and his substantial understanding of the Company gained through his service as a director since 1991, led the board to conclude that Dr. Goldstein should serve as a director. Board and Committee Membership: Board of Directors, Compensation Committee, Technology Committee. Compensation of Directors table shows $1,232,211 option awards and $75,000 fees earned in cash totaling $1,307,211.
2020-04-24	Dr. Goldstein has been a Professor of Molecular Genetics and Internal Medicine and the Chairman of the Department of Molecular Genetics at The University of Texas Southwestern Medical Center at Dallas since 1977. Dr. Goldstein is a member of the National Academy of Sciences, the National Academy of Medicine, and the Royal Society of London. He also serves on the Boards of Trustees of The Rockefeller University and the Howard Hughes Medical Institute. Drs. Goldstein and Brown jointly received the Nobel Prize for Physiology or Medicine in 1985 and the U.S. National Medal of Science in 1988. Dr. Goldstein9s extensive research experience, his distinguished scientific and academic credentials, including his receipt of the Nobel Prize for Physiology or Medicine in 1985, and his substantial understanding of the Company gained through his service as a director since 1991, led to the board9s decision to nominate Dr. Goldstein for reelection to the board. Board and Committee Membership 62019 Attendance Board of Directors 6/6 Compensation Committee 5/6* Corporate Governance and Compliance Committee 2/2* Technology Committee 4/4 * Dr. Goldstein was elected as a member of the Corporate Governance and Compliance Committee on June 14, 2019 and ceased to serve as a member of the Compensation Committee at such time. Director Compensation Joseph L. Goldstein, M.D. 2019 Total Compensation: $709,993
2021-04-23	Dr. Goldstein has been a Professor of Molecular Genetics and Internal Medicine and the Chairman of the Department of Molecular Genetics at The University of Texas Southwestern Medical Center at Dallas since 1977. Dr. Goldstein is a member of the National Academy of Sciences, the National Academy of Medicine, and the Royal Society of London. He also serves on the Boards of Trustees of The Rockefeller University and the Howard Hughes Medical Institute. Drs. Goldstein and Brown jointly received the Nobel Prize for Physiology or Medicine in 1985 and the U.S. National Medal of Science in 1988. Dr. Goldstein's extensive research experience, his distinguished scientific and academic credentials, including his receipt of the Nobel Prize for Physiology or Medicine in 1985, and his substantial understanding of the Company gained through his service as a director since 1991, led the board to conclude that Dr. Goldstein should serve as a director. Board and Committee Membership—2020 Attendance: Board of Directors: 11/11 Corporate Governance and Compliance Committee: 5/5 Technology Committee: 3/3 Prior Voting Results—2020: For: 95.1% Against: 4.9% Regeneron Securities Beneficially Owned as of April 13, 2021: Common Stock: 5,000 Options: 8,404 RSUs: 750},{
2022-04-21	Joseph L. Goldstein, M.D. Director since: 1991 Age: 81 Independent Board and Committee Membership–2021 Attendance Board of Directors: 9/9 Corporate Governance and Compliance Committee: 5/5 Technology Committee: 2/2 Director Compensation Table: Joseph L. Goldstein, M.D. Total: 710,094
2023-04-21	JOSEPH L. GOLDSTEIN, M.D. Director since: 1991 Age: 82 Independent Board and Committee Membership—2022 Attendance Board of Directors: 7/7 Corporate Governance and Compliance Committee: 5/5 Technology Committee: 2/2 Regeneron Securities Beneficially Owned as of April 11, 2023 Common Stock: 5,000 Options: 3,537 Restricted Stock Units (“RSUs”): 1,153 ... The following table and explanatory footnotes provide information with respect to compensation paid to Dr. Goldstein for their service in 2022: Total: $710,029.
2024-04-25	Joseph L. Goldstein, M.D. - Director since 1991, Age 83. Board and Committee Membership—2023 Attendance: Corporate Governance and Compliance Committee. Compensation: $709,987.